Roivant Sciences Ltd.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
Matthew Gline, who has been serving as Principal Financial Officer of the Company and Chief Financial Officer of RSI, will step down from those positions as of the Effective Date.
On September 28, 2021 (the “Effective Date”), the Company appointed Richard Pulik as Principal Financial Officer of the Company and as Chief Financial Officer of the Company’s subsidiary, Roivant Sciences, Inc. (“RSI”).
Extracted from this filing and checked against the source text.
Matthew Gline changed role as Principal Financial Officer and Chief Financial Officer at Roivant Sciences Ltd..
Matthew Gline, who has been serving as Principal Financial Officer of the Company and Chief Financial Officer of RSI, will step down from those positions as of the Effective Date.View on SEC.gov
Richard Pulik was appointed as Principal Financial Officer and Chief Financial Officer at Roivant Sciences Ltd..
On September 28, 2021 (the “Effective Date”), the Company appointed Richard Pulik as Principal Financial Officer of the Company and as Chief Financial Officer of the Company’s subsidiary, Roivant Sciences, Inc. (“RSI”).View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.